 |
Filgrastim |
|---|---|
| Trade Name | Neupogen |
| Orphan Indication | Patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir |
| USA Market Approval | USA |
| USA Designation Date | 1991-09-03 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Dr.;Thousand Oaks, California, 91320 |
